Literature DB >> 2149405

Systemic group B streptococcal disease in the neonate: characterization of an oral colonization model using the suckling rat.

L E Weisman1, L McKinney, R Villalobos.   

Abstract

Aspiration or ingestion of contaminated amniotic fluid or vaginal secretions has been suggested as a cause of systemic group B streptococcal (GBS) infection in the neonate. Suckling rat studies disagree on whether systemic disease will develop after an oral challenge of GBS. Our goal was to determine if systemic GBS disease would occur following oral colonization in the suckling rat and the effect of bacterial, host and environmental factors. Suckling rat littermates received oral inoculation on one of the first four days of life with varying doses and strains of GBS. Studies confirmed gastric inoculation without aspiration. Mortality and bacteremia decreased with age, increased with dose, varied with strain, and increased with asphyxia. Autopsy confirmed sepsis, intestinal colonization, meningitis, and pneumonia. Bacteremia was associated with an abnormal immature: total neutrophil ratio at 24 hr, thrombocytopenia at 48 hr, and neutropenia at 72 hr after inoculation. GBS can cause systemic infection in the host after oral colonization which appears age-, dose, strain-, and environment-dependent. Evaluation of GBS entry in the susceptible host may facilitate therapies directed toward preventing mucosal invasion.

Entities:  

Mesh:

Year:  1990        PMID: 2149405     DOI: 10.1111/j.1348-0421.1990.tb01053.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  2 in total

1.  Effect of prenatal cortisone on spontaneous bacterial translocation from gastrointestinal tract in neonatal rat.

Authors:  Heimo H Wenzl; Günter Schimpl; Gebhard Feierl; Gerhardt Steinwender
Journal:  Dig Dis Sci       Date:  2003-06       Impact factor: 3.199

2.  Naturally occurring disseminated group B streptococcus infections in postnatal rats.

Authors:  Katherine A Shuster; Gerald A Hish; Lindsi A Selles; Mahboob A Chowdhury; Roger C Wiggins; Robert C Dysko; Ingrid L Bergin
Journal:  Comp Med       Date:  2013-02       Impact factor: 0.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.